Biotech · Private company
Mirador Therapeutics, Inc.
Track this companyFree. Adds Mirador Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials64 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- MT-201Phase 2 · Inflammatory Bowel Disease (IBD)ClinicalTrials.gov · fetched Nov 12, 2026
- MT-501Phase 2 · Inflammatory Bowel Disease (IBD)ClinicalTrials.gov · fetched Nov 12, 2026
- MT-201Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- MT-251Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MT-501Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MT-701Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy ParticipantsPHASE1 · RECRUITING · started Jul 16, 2026ClinicalTrials.gov NCT07776782 · fetched Nov 12, 2026
- A First-in-Human Single and Multiple Ascending Dose Study of MT-251PHASE1 · RECRUITING · started Jan 23, 2026ClinicalTrials.gov NCT07423299 · fetched Nov 12, 2026
- A First-in-Human Single and Multiple Ascending Dose Study of MT-701PHASE1 · COMPLETED · started Jan 12, 2026ClinicalTrials.gov NCT07396909 · fetched Nov 12, 2026
- A First-in-Human Single and Multiple Ascending Dose Study of MT-201PHASE1 · RECRUITING · started Oct 8, 2025ClinicalTrials.gov NCT07219368 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseasePHASE2 · RECRUITING · started Jun 26, 2025ClinicalTrials.gov NCT07113522 · fetched Nov 12, 2026
- A First-in-Human Single and Multiple Ascending Dose Study of MT-501PHASE1 · COMPLETED · started Dec 11, 2024ClinicalTrials.gov NCT06762457 · fetched Nov 12, 2026